prof. dr. Annemieke Madder
work address
Krijgslaan 281, S4
9000 Gent
9000 Gent
ORCID iD
https://orcid.org/0000-0003-0179-7608
1 – 10 of 221
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Design and syntheses of highly potent teixobactin analogues against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE) in vitro and in vivo
- 2017
- Injectable peptide-based hydrogel formulations for the extended in vivo release of opioids
- Injectable peptide-based hydrogel formulations for the extended in vivo release of opioids
- Synthetic protocol for AFCS : a biologically active fluorescent castasterone analog conjugated to an Alexa Fluor 647 dye
- Teixobactin analogues reveal enduracididine to be non-essential for highly potent antibacterial activity and lipid II binding
- Decoration of trastuzumab with short oligonucleotides : synthesis and detailed characterization
- Visible-light-mediated selective arylation of cysteine in batch and flow
- Synthesis and improved cross-linking properties of C5-modified furan bearing PNAs
- Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of L-allo-enduracididine with its isosteres
- Singlet oxygen-mediated one-pot chemoselective peptide–peptide ligation